HumaFIA

“During our trial period, we had the opportunity to test CRP using HumaFIA in STAT sample mode. The experience left us thoroughly impressed. What stood out the most was the user-friendliness of HumaFIA. Its intuitive interface and streamlined process made testing remarkably easy. We were equally amazed by the speed at which results were generated, without compromising accuracy. The consistency of reproducible results was another notable feature that boosted our confidence in the system.”

“HumaFIA has been a game-changer for our laboratory. We are delighted by the substantial improvement HumaFIA has brought to our acute myocardial infarction diagnosis capabilities, overcoming challenges related to availability and diagnostic limitations encountered with other systems. This has been particularly impactful as a significant majority of our patients, approximately 80%, exhibited troponin levels below 0.1 ng/ml. Since implementing HumaFIA, we have experienced reliable and efficient cardiac marker testing. The stability and ready-to-use nature of the reagents simplify our process, allowing us to store the kits at a 4 to 30° C. The direct testing of whole blood without sample pretreatment has reduced manual steps and eliminated the need for additional buffers. We highly recommend HumaFIA to other laboratories and healthcare facilities in need of a superior cardiac marker testing solution.

The HUMAFIA® instrument presents with a good compact and robust shape. The size is suitable and the instrument easily fits on a laboratory bench, even a narrow one. No issue was observed during the installation of the instrument, and it functioned well with our electrical voltage and power. PROCALCITONIN assay (PCT): Procalcitonin testing was performed for targeted groups of patients presenting with fever. The conclusion is that the assay is really strongly correlated and predictive of bacterial infection Patients presenting with cryptococcal infections or tuberculosis did not have high values. The test also helped to diagnose potential bacterial infection in cancer patients, helping to differentiate with para neoplasic fever.